Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet

Du verkar använda en bredare skärm. Vill du aktivera en bredare visningsupplevelse på denna sida?

Audientes – Presentation of Q2/H1 2024 report

Av Michael FriisHead of Equities
Audientes

You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.

Audientes expects to release its H1 results on 29 August 2024. Audientes’ CEO Steen Thygesen will present the results, provide a business update, and answer questions at a virtual live event on 30 August at 13.00.

In the Q1 2024 results, Audientes realized around DKK 0.2m in revenue, but lowered the loss to DKK 2.6m (DKK 3.8m in Q1 2023). In the second quarter, Audientes made a rights issue that was subscribed to 94 percent, corresponding to approximately DKK 4.59 million in new capital and conversion of debt. Furthermore, they have announced new distribution partners in India, the Middle East, and Africa. After the period, they also signed a definitive agreement for a joint venture on the Chinese market. The expectations for those agreements and the capital situation will be in focus besides the financial results.

Audientes A/S is a Danish hearing health company specializing in smart, self-fitting affordable hearing aids and advanced hearables. Audientes’ unique hearing aid solution, Ven™ by Audientes, is available for purchase in the Indian and Nepalese markets and is expected to be introduced in other markets in the coming years.

Disclaimer: HC Andersen Capital receives payment from Audientes for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 13.34, 19 August 2024.

Recent videos

Incap India’s production and testing director interviewed
2025-11-14 15:10 Incap
NIBE, Audiocast, Q3'25
2025-11-14 11:00 Nibe Industrier
Björn Borg Q3´25: "Vi vill helst växa mycket mer"
2025-11-14 10:09 Björn Borg
Egetis Therapeutics, Audiocast, 2025
2025-11-14 10:00 Egetis Therapeutics
Mendus, Audiocast, Q3'25
2025-11-13 14:00 Mendus
Titta på alla videos
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.